Clinical Trial Update: VRS-317 in Adult Subjects With Growth Hormone Deficiency [Phase 1]

View source ↗

Summary

Phase 1 trial update for VRS-317 in adults with growth hormone deficiency, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• VRS-317

Snippet

Sponsor: Versartis Inc. | Conditions: Growth Hormone Deficiency | Phase 1 | Status: COMPLETED